Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-023769
Filing Date
2016-06-28
Accepted
2016-06-28 16:48:03
Documents
2
Period of Report
2016-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1537
2 EX-24 DOCUMENT attachment1.htm EX-24 3649
  Complete submission text file 0000899243-16-023769.txt   6503
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
GALA RENEE D (Reporting) CIK: 0001607737 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50679 | Film No.: 161736597